Try the modernized beta website. Learn more about the modernization effort.
Working… Menu
Trial record 5 of 11 for:    arbaclofen autism

Arbaclofen vs. Placebo in the Treatment of Children and Adolescents With ASD (ARBA) (ARBA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03887676
Recruitment Status : Active, not recruiting
First Posted : March 25, 2019
Last Update Posted : June 22, 2022
Holland Bloorview Kids Rehabilitation Hospital
McMaster University
University of Western Ontario, Canada
Queen's University
Unity Health Toronto
University of Toronto
Information provided by (Responsible Party):
Evdokia Anagnostou, Anagnostou, Evdokia, M.D.

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : August 31, 2022
Estimated Study Completion Date : August 31, 2022